In line with these observations, an antibiotic agent known as thiostrepton, or TST, has been reported as a potent TLR-9 inhibitor [11], but to the best of our knowledge, it has not been previously explored as a potential treatment for sepsis. The gene discussed is TLR9; the disease is Sepsis.